Data / Form D filings / Traws Pharma, Inc.
Traws Pharma, Inc.: Form D filings
Traws Pharma, Inc., a biotechnology company in Newtown, PA, filed 11 Form D notices with the SEC between 2009 and 2024. The latest, on April 16, 2024, reports $14 million sold of a $14 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 Penns Trail, Newtown, PA, 18940
- Phone
- (267) 759-3680
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1130598
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2024 | New notice | $14,000,000 | $14,000,000 | 2 | Apr 1, 2024 | sec.gov | |
| Jun 4, 2019 | New notice | $2,000,000 | $500,000 | $1,500,000 | 1 | May 10, 2019 | sec.gov |
| Jun 8, 2018 | New notice | $1,250,000 | $1,250,000 | 1 | Apr 5, 2018 | sec.gov | |
| Oct 23, 2015 | New notice | $16,500,000 | $1,500,000 | $15,000,000 | 1 | Oct 8, 2015 | sec.gov |
| Aug 13, 2012 | New notice | $49,999,999 | $49,999,999 | 1 | Jul 27, 2012 | sec.gov | |
| Jul 26, 2012 | Amendment | $30,000,000 | $26,444,316 | $3,555,684 | 41 | Apr 27, 2012 | sec.gov |
| May 10, 2012 | New notice | $30,000,000 | $7,050,000 | $22,950,000 | 4 | Apr 27, 2012 | sec.gov |
| Jan 5, 2011 | Amendment | $20,000,000 | $11,690,190 | $8,309,810 | 67 | Sep 21, 2010 | sec.gov |
| Oct 4, 2010 | New notice | $15,000,003 | $6,545,613 | $8,454,390 | 32 | Sep 21, 2010 | sec.gov |
| Mar 4, 2010 | Amendment | $26,309,969 | $19,226,287 | $7,083,682 | 58 | May 12, 2009 | sec.gov |
| May 26, 2009 | New notice | $23,496,000 | $5,260,773 | $18,235,227 | 18 | May 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| M. Theresa Shoemaker | Director | |
| Jack E. Stover | Director | |
| Trafford Clarke | Director | |
| Nikolay Savchuk | Director, Executive Officer | |
| Ian Dukes | Director | |
| David Pauza | Executive Officer | |
| Robert Redfield | Executive Officer | |
| Mark Guerin | Executive Officer | |
| Steven Fruchtman | Executive Officer | |
| Werner Cautreels | Director, Executive Officer | |
| James Marino | Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Apr 15, 2024 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Traws Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.